Affiliation:
1. the Cleveland Clinic Foundation (D.L.S.), Preventive Cardiology, Cleveland, Ohio; Lipid Research Division (D.L.S., B.V.H., L.A.S.), Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio; Medical Research Laboratories and The Christ Hospital Cardiovascular Research Center (E.A.S.), Cincinnati, Ohio; Department of Pediatrics (P.S.B.), Children's Hospital Medical Center, Cincinnati, Ohio; and Center for Lipids (L.M.K.), Division of Cardiology, Maine Medical Center, Portland, Me.
Abstract
BackgroundHeterozygous lipoprotein lipase (LPL) deficiency has been associated with familial hypertriglyceridemia and familial combined hyperlipidemia. Studies of heterozygotes withLPLgene defects at amino acid residues 188 and 207 showed higher triglycerides (TG) and lower HDL cholesterol (HDL-C), with no elevation in LDL cholesterol (LDL-C). OtherLPLdefects may reveal alternate clinical phenotypes.Methods and ResultsWe evaluated three families with defects at amino acid residues 64, 194, and 188. Thirty-eight heterozygotes (8 with defect 64, 14 with defect 194, and 16 with defect 188) and 95 family members without defects were studied. Plasma lipid, lipoprotein, and apolipoprotein (apo) values were measured, as well as blood pressure. Pooled carriers demonstrated higher systolic blood pressure (SBP) (127 versus 116 mm Hg,P<.0001) and TG (160 versus 125 mg/dL,P=.004) and lower HDL-C (44 versus 52 mg/dL,P=.001) than did noncarriers. A comparison of the 188 carriers and noncarriers revealed the most striking phenotypic characteristics, with lower HDL-C (36 versus 51 mg/dL,P<.0001) and HDL-C/(apo A-I + apo A-II) (0.21 versus 0.24,P=.002) and higher TG (206 versus 123 mg/dL,P=.0003), SBP (132 versus 116 mm Hg,P=.0004), and apo B/LDL-C (1.12 versus 0.93,P<.0001).ConclusionsThese data confirm past observations that LPL deficient heterozygotes trend toward lower HDL-C and higher TG levels while potentially expressing higher SBP. These data also implicate the specificLPLgene defect as a contributing factor to the variable expression of HDL-C, TG, and SBP.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献